Price $0.40 |
Market Cap
59.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
6.1
|
P/B
-
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-
|
|
ROA
-
|
EPS Growth
-
|
Current Ratio
5.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Therapeutics Inc (ASRT) | $3.18 | - | - | 202.9M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $5.82 | - | - | 106.5M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $49.01 | - | - | 1.31B | Strong Buy |
| Premier Inc (PINC) | $39.44 | - | - | 4.68B | Strong Buy |
| MTBC Inc (MTBC) | $4.68 | - | - | 58.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
